Nevro Corp (NYSE:NVRO) reported earnings of ($0.35) per share missing Walls Streets expectations.

ME Staff
-
0

Nevro Corp (NYSE:NVRO) reported Q2 2018 earnings this Afternoon, coming in at ($0.35) per share, missing Wall Street’s estimates of ($0.32) per Share. Revenue for the quarter came in at $96.10 million in-line expectations of $96.10 million

Recent Insider Trading for Nevro Corp (NYSE:NVRO)

  • On 5/14/2018 Andrew H. Galligan, CFO, sold 7,000 with an average share price of $76.14 per share and the total transaction amounting to $532,980.00.
  • On 3/7/2018 Wilfred E Jaeger, Director, sold 160,542 with an average share price of $80.77 per share and the total transaction amounting to $12,966,977.34.
  • On 3/5/2018 Wilfred E Jaeger, Director, sold 42,116 with an average share price of $80.19 per share and the total transaction amounting to $3,377,282.04.
  • On 3/1/2018 Andrew H. Galligan, CFO, sold 7,000 with an average share price of $80.10 per share and the total transaction amounting to $560,700.00.
  • On 3/1/2018 Wilfred E Jaeger, Director, sold 10,000 with an average share price of $80.48 per share and the total transaction amounting to $804,800.00.
  • On 2/27/2018 Wilfred E Jaeger, Director, sold 14,458 with an average share price of $83.28 per share and the total transaction amounting to $1,204,062.24.



    About Company
    Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. Its solution for chronic pain also includes HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was founded in 2006 and is headquartered in Redwood City, California.

    Recent Analyst Rating for Nevro Corp (NYSE:NVRO)



      Recent Trading for Nevro Corp (NYSE:NVRO)
      Shares of Nevro Corp closed the previous trading session at 59.55 up +1.15 1.97% with 58.13 shares trading hands.